Scholarlink

<p>Point-of-care testing (POCT) requires rapid, quantitative results without the complexity of laboratory instrumentation. Conventional assays like ELISA and PCR are often limited by long processing times, multiple washing procedures, and a dependence on bulky, external power-consuming pumps. To address these challenges, we developed a fully integrated, palm-sized platform validated with two high-impact biomarkers: thrombin, a critical regulator of blood coagulation for cardiovascular and renal diagnostics, and the SARS-CoV-2 spike protein, a primary antigen for rapid viral screening. The platform’s innovation lies in its user-independent, electricity-free fluidic operation, featuring a manual suction pump with a compression spring that ensures high reproducibility (CV &lt; 4.5%). Additionally, a serpentine microchannel design was incorporated to promote Dean flow-induced inertial mixing, accelerating aggregation kinetics for a true wash-free plasmonic assay. Our system provides real-time quantitative detection within 5 min, achieving sub-nanomolar limits of detection (LoD: 0.5 nM for thrombin and 0.4 nM for spike protein). Wireless connectivity allows for immediate data visualization on smartphones. By bridging the gap between sophisticated laboratory analysis and portable, manual operation, this platform offers a robust and scalable solution for decentralized clinical diagnostics.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Microfluidic–optical integrated portable platform with handheld pump for wash-free plasmonic detection of thrombin and SARS-CoV-2 spike protein

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月17日

查看全文
  • Da-In Kwon,
  • Yeong-Eun Yoo,
  • Jae-Ho Jin,
  • Ji Hyo Park,
  • Ga Eun Han,
  • Kwanoh Kim,
  • Jae Sung Yoon,
  • Seong Min Kang,
  • Do Hyun Kang

摘要

Point-of-care testing (POCT) requires rapid, quantitative results without the complexity of laboratory instrumentation. Conventional assays like ELISA and PCR are often limited by long processing times, multiple washing procedures, and a dependence on bulky, external power-consuming pumps. To address these challenges, we developed a fully integrated, palm-sized platform validated with two high-impact biomarkers: thrombin, a critical regulator of blood coagulation for cardiovascular and renal diagnostics, and the SARS-CoV-2 spike protein, a primary antigen for rapid viral screening. The platform’s innovation lies in its user-independent, electricity-free fluidic operation, featuring a manual suction pump with a compression spring that ensures high reproducibility (CV < 4.5%). Additionally, a serpentine microchannel design was incorporated to promote Dean flow-induced inertial mixing, accelerating aggregation kinetics for a true wash-free plasmonic assay. Our system provides real-time quantitative detection within 5 min, achieving sub-nanomolar limits of detection (LoD: 0.5 nM for thrombin and 0.4 nM for spike protein). Wireless connectivity allows for immediate data visualization on smartphones. By bridging the gap between sophisticated laboratory analysis and portable, manual operation, this platform offers a robust and scalable solution for decentralized clinical diagnostics.